講演・口頭発表等 - 森尾　友宏

分割表示  1,053 件中 141 - 160 件目  ／  全件表示 >>

  1. Morio T. . Ataxia-Telangiectasia in Japan:Phenotypic variations in affected siblings with Ataxia-Telangiectasia. . Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga

  2. Morio T. . Immunodefiencies with impaired DNA damage response.. Recent Advances in DNA Damage Response. 2008.04

  3. Mizutani S, Unno J, Watanabe F, Takagi M ,Morio T, Teraoka H, Domenico D.. Regulation of Artemis/ATM-related DNA damage response network.. Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  4. Nakamura K, Morio T, Mizutani S,. Identification of Novel Mutation in Japanese Patients with Ataxia Telangiectasia ; Absence of Founder Mutations.. Ataxia- TelangiectasiaWorkshop 2008. 2008.04 Otsu, Shiga,

  5. Unno J, Takagi M, Watanabe F, Sato M, Takahashi N, Morio T, Teraoka H, Mizutani S. . Generation of DNA double-stranded breaks in stalled DNA replication forks: an essential step initiated by Artemis toward a second wave of DNA damage response and ATM activation.. Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  6. Watanabe F, Morio T, Ogigami N, Kiyono T, Delia D, Mizutani S.. Stability of Artemis protein is regulated by Hsp72. . Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  7. Morio T. . Strategy to combat opportunistic infections after umbilical cord stem cell transplantation.. The 5th Annual International Umbilical Cord Blood Transplantation Symposium. 2007.05 California, USA.

  8. Morio T. . Immunity & Nutrition, Its importance in post-transplantation period.. Symposium on Infection, Immunity and Nutrition. 2007.03 Seoul, Korea

  9. Morio T. . Strategy to combat opportunistic infections aft Seoul, Korea.er stem cell transplantation. . The 11th Congress of Asian-Pacific Bone Marrow Transplantation. 2006.10 Nagoya, Japan.

  10. Morio T. . Cell cycle checkpoint. DNA repair system. and Carcinogenesis. . International Symposium on Gastrointestinal Disorders: Molecular Mechanisms of Pathogenesis. in Commemoration of 120th Anniversary of Yonsei Univeisity. College of Medicine. 2005.06 Seoul, Korea.

  11. Morio T. . Activated T-Cell Transfusion for Opportunistic Infection in Immunodeficient Patients and for Post-transplant Infections.. The 2nd International Symposium "New Challenges in the Post Genome Era 2003" 2003.11 Seoul, Korea.

  12. Morio T. . Activated T-Cell transfusion for opportunistic infection in immunodeficient patients and for post-transplant infections.. The 10th Meeting of Transplantation/ Immunoregulation 21. 2003.11 Tokyo, Japan.

  13. Morio T. . Activated T-Cell Transfusion for Opportunistic Infection in Immunodeficient Patients.. Nihon University School of Medicine Symposium “Cell Biology of Virus Infection” 2003.10 Tokyo, Japan.

  14. Morio T. . Molecular Basis of Primary Immunodeficiency.. The 46th Meeting of Korean Association of Immunobiologists 2003.04 Seoul, Korea.

  15. Morio T. . Ku70/80, A DNA Repair Protein Involved in Cellular Survival, Transformation, and Death.. 2002 International Symposium on Exocrine Pancreas 2002.08 Seoul, Korea.

  16. Morio T. . Proteomics approach for elucidating signal transduction pathway. Symposium: "Genomics and Proteomics in Pharmacology" . Annual Meeting of Korean Society of Pharmacology 2001.04 Seoul, Korea.

  17. Morio T. . Proteomics approach for elucidating signal transduction pathway. Symposium: "Genomics and Proteomics in Pharmacology". Annual Meeting of Korean Society of Pharmacology 2001.04 Seoul, Korea.

  18. Morio T. . Identification of CD40-associated protein by protein microsequencing and ESI-MS.. In Proteomics and Genomics in Biotechnology, The 8th Bioproduct Research Center International Symposium. 2000.06 Seoul, Korea.

  19. 石橋佑脩,谷田けい,磯田健志,小林法元,座波清誉,野々山恵章,今井耕輔,髙木正稔,森尾友宏,金兼弘和. 5'-非翻訳領域にバリアントを認めたX連鎖無ガンマグロブリン血症. 第9回日本免疫不全・自己炎症学会総会・学術集会 2026.02.14 仙台

  20. 森尾友宏. バリアントの機能による分類と疾患の表現型：IKZF異常症とOAS異常症. 自己炎症性疾患における遺伝学的検査勉強会 2025.09.12 東京

< 前のページ - 次のページ >

このページの先頭へ▲